Björn ArnsvikHead of Facilities & EHS
MSc Mech Eng., has over 30 years of experience in the pharmaceutical industry and has held management positions at companies such as Astra Zeneca, Pharmacia and Thermo Fisher Scientific. Björn joined Cernelle in 2016.
Fredrik HåkanssonCFO
MSc Economics and an Executive MBA, has more than 20 years of experience in managerial positions in various industries, including medicine technology and among others from companies such as Nolato and Enzymatica. Fredrik joined Cernelle in 2019.
Anette Victor MendesHead of Quality Assurance
MSc Chem Eng, has almost 30 years of experience of the pharmaceutical industry and Quality Assurance at companies such as AstraZeneca and Recipharm. Anette joined Cernelle in 2023
Matilda AhlgrenHead of Quality Control & Development
BSc Chemical Eng., has over 15 years of experience in the pharmaceutical industry in different roles both in R&D and Supply Chain at companies such as Pharmacia and Johnson & Johnson. Matilda joined Cernelle in 2019
Caroline GranqvistHead of Operations
MSc Chemical Eng / Biotechnology, has more than 20 years of experience within various manufacturing industries, in areas such as Operations and R&D. Has held several managerial positions, including in the pharmaceutical industry at companies such as Johnson & Johnson. Caroline joined Cernelle in 2024.
Dr Hans FeldmeierChairman of the Executive Committee
Pharmacist, has more than 35 years of experience in the pharmaceutical industry and has held executive commercial roles at companies such as; Berlin-Chemie AG (Menarini Group), Schering AG, and Dermapharm AG. Acting CEO of Dermapharm SE since 2018. Dermapharm AG acquired AB Cernelle December 1st 2021.
Dörte MünsterMember of the Executive Committee
Has more than 30 years of experience within the pharmaceutical industry.
She joined Strathmann GmbH & Co. KG in 1988, as Head of the Supply Chain Division.
Acting CEO since 2018, when Dermapharm acquired the company.
She joined Strathmann GmbH & Co. KG in 1988, as Head of the Supply Chain Division.
Acting CEO since 2018, when Dermapharm acquired the company.
Ken TineboMember of the Executive Committee
Ken Tinebo, MBA, has more than 30 years of experience in the pharmaceutical industry and has held executive commercial roles at companies such as Danone Medical Nutrition, Orion Pharma, Astra Zeneca and Pharmacia.
Cernelle’s CEO since August 2015.
Cernelle’s CEO since August 2015.